NMDAR in bladder smooth muscle is not a pharmacotherapy target for overactive bladder in mice

Volume: 9, Pages: e11684 - e11684
Published: Jul 7, 2021
Abstract
Overactive bladder (OAB) is a common condition that affects a significant patient population. The N-methyl-D-aspartate receptor (NMDAR) has a role in developing bladder overactivity, pharmacological inhibition of which inhibits bladder overactivity. The common pathogenesis of OAB involves bladder smooth muscle (BSM) overactivity. In this study, a smooth muscle–specific NMDAR knockout ( SMNRKO ) mouse model was generated. The bladders from SMNRKO...
Paper Details
Title
NMDAR in bladder smooth muscle is not a pharmacotherapy target for overactive bladder in mice
Published Date
Jul 7, 2021
Journal
Volume
9
Pages
e11684 - e11684
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.